EUCTR2013-001688-22-ES进行中（未招募）不适用
Randomized multicenter trial in colorectal cancer patients with non-resectable metastasis. Impact of tumor resection versus chemotherapy alone in survival. - CCRe-IV
Servicio de Cirugía General y Digestiva Hospital Universitario de Bellvitge0 个研究点开始时间: 2013年6月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Primary adenocarcinoma of the colon or upper rectum. Only include rectal tumors located above 12 cm from the anal margin (the distance from the anal verge will be evaluated by rigid proctoscopy if in doubt).
- •- Radiologically resectable primary tumor (as CT or MRI).
- •or In the case of higher rectum tumor, no infiltration of vascular, nerve or bone.
- •or in cases of colorectal tumor invasion T4 with neighboring organs (abdominal wall, uterus, bladder, small intestine, liver segment, gall bladder, second or fourth portion of the duodenum, pancreas tail or greater curvature of the stomach) measured radical resection.
- •- No urgent or emergent surgery of the primary tumor by an event related to the same. In the case of occlusion and endoluminal stenting with clinical success, the patient may be included in the randomization.
- •- Radiological Confirmation unresectable synchronous metastases, both liver and in other locations. Unresectability criteria will be evaluated by a Committee of Experts on the Functional Unit of Colorectal Cancer of each center or by a multidisciplinary team.
- •- Absence of peritoneal carcinomatosis in the radiological study.
- •- Before completing any study-related procedures listed in Section 6.3, the patient must give informed consent to participate, in writing, signed and dated.
- •- Staging performed in less than 3 weeks prior to randomization.
- •- No contraindications for chemotherapy.
- •- ECOG performance status ? 2.
- •- Patient considered mentally and physically fit to receive chemotherapy and surgical treatment, judging by the multidisciplinary team.
- •- Age ? 18 years.
- •- Not pregnant or nursing.
- •- Negative pregnancy test in patients of childbearing age.
- •- Adequate monitoring potential.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 56
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 280
排除标准
- •- Infiltration of bone structures, vascular or nerve root infiltration of the superior mesenteric artery or the head of the pancreas.
- •- Presence of multiple bone metastatic disease or central nervous system.
- •- Concomitant neoplastic disease in the past 5 years except basal cell carcinoma or squamous skin or carcinoma in situ of the cervix.
- •- Medical or psychiatric condition that compromises the patient's informed consent authorization.
- •- Uncontrolled concomitant medical pathology or stable that could compromise the tolerance to chemotherapy.
- •- Patients with malabsorption syndromes or physical loss of the integrity of the upper digestive tract.
- •- Clinically significant cardiac pathology (congestive heart failure, symptomatic coronary artery disease) and myocardial infarction in the last 6 months.
- •- Patients with symptoms or symptoms of peripheral neuropathy.
- •- Refusal to participate in the study.
研究者
相似试验
已完成
不适用
multicenter study for treatment of colon cancerColon cancerJPRN-UMIN000038707Yokohama city university315
进行中（未招募）
1 期
A study comparing the effect of chemotherapy with the effect of chemotherapy plus local removal of metastases for patients with cancer of the large bowel which has spread to multiple organs.multi-organ metastatic colorectal cancerMedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2011-005003-32-NLVU University Medical Center, Department of Medical Oncology478
招募中
不适用
A randomized multicenter clinical trial for patients with multi-organ colorectal cancer metastases comparing the combination of chemotherapy and maximal tumor debulking versus chemotherapy alone.NL-OMON54652Radboud Universitair Medisch Centrum408
进行中（未招募）
不适用
A randomised multicenter clinical trial for patients with multi-organ, colorectal cancer metastases comparing the combination of chemotherapy and removing as many visible tumors as possible by surgery or other means versus chemotherapy aloneMulti-organ, colorectal cancer metastasesCancerISRCTN15067672Radboud University Medical Centre Nijmegen (Netherlands)478
尚未招募
不适用
A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiencyITMCTR2000003805Shanghai Municipal Hospital of Traditional Chinese Medicine